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Appropriate PI3K signals generated by the antigen receptor are essential to promote
B cell development. Regulation of recombination activating gene (RAG)-1 and RAG-2
expression is one key process that is mediated by PI3K to ensure developmental
progression and selection.When PI3K signals are too high or too low, expression of RAGs
does not turn off and B cell development is impaired or blocked. Yet, the mechanism
which tunes PI3K activity to control RAG expression during B cell development in the
bone marrow is unknown. Recently we showed that a c-Myc/miR17-92/PTEN axis
regulates PI3K activity for positive and negative selection of immature B cells. Here, we
show that the c-Myc/miR17-92/PTEN axis tunes PI3K activity to control the expression
of RAGs in proB cells. Using different genetically engineered mouse models we show that
impaired function of the c-Myc/miR17-92/PTEN axis alters the PI3K/Akt/Foxo1 pathway
to result in dis-regulated expression of RAG and a block in B cell development. Studies
using 38c-13 B lymphoma cells, where RAGs are constitutively expressed, suggest that
this regulatory effect is mediated post-translationally through Foxo1.
Keywords: B cell development, recombination activating gene (RAG), PI3K–AKT pathway, microRNA, PTEN
(phosphatase and tensin homolog)
INTRODUCTION
The development of B lymphocytes in the bone marrow (BM) is a highly regulated process guided
by the successive attempts to recombine immunoglobulin (Ig) genes and to assemble the B cell
antigen receptor (BCR). Recombination activating gene (RAG)-1 and RAG-2 are key enzymes in
this process and their expression is tightly regulated by signals generated by the antigen receptor to
promote developmental progression through negative and positive selection check-points. Binding
self-antigens activates tolerance mechanisms in immature and transitional B cells (1–3), whereas
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appropriate ligand-independent (tonic) signals are necessary for
positive selection, developmental progression and maturation
(4, 5). Thus, tonic signals, which are transmitted by the precursor
BCR (preBCR), stimulate proliferative expansion of proB cells
(6, 7), and those transmitted by the BCR promote developmental
progression and maturation of immature B cells expressing non-
harmful receptors (8–10). Failure to express preBCR or BCR
or their signaling or surface regulatory components impairs or
blocks B cell development (4, 11, 12).
The phosphoinositide 3-kinase (PI3K) activity is critical for
B cell development and survival (12–16). Tonic PI3K signaling
regulates expression of RAGs and is therefore essential for
positive selection at the proB and immature B cell stages. Foxo1 is
a major transcription factor necessary to induce the transcription
of both RAGs. In developing B cells the expression and function
of Foxo1 are directly regulated through phosphorylation and
inactivation by the PI3K/Akt pathway (17, 18). When PI3K
signals are too low, such as in CD19-deficient (CD19KO)
B cells or when antigen receptor is ablated, continues RAG
expression results in ongoing rearrangements (9, 14, 19–21).
On the other hand, PI3K signals that are too high, such as in
PTEN-ablated B cells, suppress RAG expression and impose a
severe developmental block at the proB stage (22). These studies
show that generation of appropriate PI3K activity is crucial to
control RAG levels, thus allowing for proper developmental
progression. However, the exact physiological mechanism and/or
biochemical circuit which tunes PI3K activity to control RAG
expression at these early stages of B cell development are
unknown.
MicroRNAs were shown to regulate B lymphocyte fate
at multiple levels, affecting physiological processes such
as development, differentiation, and function (23–26).
Recently, we showed that miRNAs are essential to regulate
the PI3K/Akt/Foxo1 pathway and RAG expression in peripheral
B cells (27). In another work, we reported an autostimulatory axis
by which the PI3K regulates expression of its main antagonistic
phosphatase, phosphatase and tensin homolog (PTEN). This
autostimulatory axis is composed of a transcription factor
c-Myc, a microRNA miR17-92, and a signaling molecule
PTEN (c-Myc/miR17-92/PTEN axis) and controls PI3K activity
for positive and negative selection of immature B cells (28).
According this axis, c-Myc, whose expression levels are regulated
by PI3K, directly controls expression of miR17-92, which
post-transcriptionally promotes degradation of PTEN mRNA
to dampen PTEN protein levels and to enhance PI3K activity.
The resulting enhanced PI3K further promotes expression of
high levels of c-Myc and survival of B cells (see also Figure 8).
In the present study, we explored the role of the c-Myc/miR17-
92/PTEN axis in regulating RAG expression at early stages
of B cell development. We show that in proB cells the c-
Myc/miR17-92/PTEN axis tunes expression of RAG through
controlling the activity of PI3K. Using different conditional
mutated mouse models we show that impaired function of the
c-Myc/miR17-92/PTEN axis alters the PI3K/Akt/Foxo1 pathway
to result in dis-regulated expression of RAG and a block in B
cell development. In further studies we used 38c-13 B lymphoma
cells, where RAG genes are constitutively expressed, to suggest




miR17-92fl/fl (29), ROSA26STOPflox PTEN-2AYFP (PTENover)
(30), ROSA26STOPflox-P110∗ (16), CD19KO (31), miR17-92Tg
mice (32), and mb1-cre (33) mice have been described. All
mice are C57BL/6 or have been backcrossed to the C57BL/6
background for more than 10 generations. Mice were housed
and bred at the animal facility of the Technion, Faculty of
Medicine (Israel) or at the Max Delbrück Center for Molecular
Medicine (Berlin, Germany) or at the University of Colorado,
School of Medicine (Aurora CO, United States) and used
for experiments at 10–12 weeks of age. Mouse studies at
the Technion were approved by the local committee for the
supervision of animal experiments. Animal care in Berlin
followed guidelines of the Max Delbrück Center for Molecular
Medicine and the governmental review board (Landesamt
für Gesundheit und Soziales Berlin, LaGeSo). Animal studies
at University of Colorado were performed in accordance
with the regulations and with approval of the University
of Colorado Denver Institutional Animal Care and Use
Committee.
Cells and Transfection
38c13 cells (34) were cultured in standard RPMI. Cells were
infected with different viral vectors to express a sponge system
to miR-19b or to the complete miR17-92 cluster, overexpress
PTEN or knockdown PTEN (shPTEN) (see supplemental
details). Stable transfectants were selected and used for the
experiments. Cells were lysed (see Supplemental Details in
methodology) for western blotting and quantification of mRNAs.
In some experiments a specific inhibitor for Foxo1 transcription
activity AS1842856 (Calbiochem) was added to the cultured
cells at 14µM for 2 h. In some experiments HEK cells
were transfected with vectors encoding luciferase reporter
bound to 3′UTR of PTEN or Foxo1 as detailed in the
Supplementary Section. IL-7-driven BM cultures for B cell
precursors were prepared as previously described (35). Cells
grown in these primary cultures were harvested after 5 days
(>95% B220+) and were used as detailed. In some experiments
B cell precursors were grown in IL-7 driven BM cultures
(36) and cells were treated with 1µM miR19b antagomirs
(Exiqon).
Flow Cytometry and Cell Sorting
Single cell suspensions from mouse BM or spleen were stained
with fluorescently labeled antibodies for surface and intracellular
proteins to identify specific B cell subsets. Antibodies for the
following surface markers were used: αB220-BV785 (RA3-6B2),
αCD19-BV605 (6D5), αCD93-APC (AA4.1), αB220-PB (RA3-
6B2), αCD25-PE (3C7), αc-kit-BV605 (ACK2) from BioLegend,
αCD1d-PE (1B1) from eBioscience. Antibodies for intracellular
staining used were anti pAkt (4060) and anti PTEN (p559)
from Cell Signaling using the BrdU fixation kit (552598) from
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BD. Data were acquired on LSRFortessa (BD Pharmingen) and
analyzed using FlowJo software (Tree Star). In some experiments
cells of specific populations based on surface markers expression
were sorted using FACSAria (BD).
Western Blot Analysis
Western blots were performed as we have previously described
(37). Briefly, cells were lysed in RIPA buffer containing
complete protease inhibitor cocktail (Roche Diagnostics), 1mM
sodium orthovanadate, 5mM sodium fluoride and 0.5mM
phenylmethylsulfonyl fluoride. Proteins were separated by SDS-
PAGE and transferred to polyvinylidene fluoride membrane
(Millipore, Bedford, MA, United States). Blots were probed
with rabbit anti-phospho-Akt (Ser473) (Cat 4060), rabbit anti-
Akt (Cat 9272), rabbit anti-PTEN (Cat 9188), (all from Cell
Signaling), rabbit anti-Foxo1(Santa Cruz), mouse anti-actin (C4)
(from MP biomediacls). To reveal bound Abs we used HRP
conjugated secondary Abs. Blots were developed with ECL
reagent (Pierce).
Viral Vectors
To suppress miR19b or the entire miR17-92 cluster in 38c13 cells
we used pMSCV-PIG-sp19 or pMSCV-PIG-sp17-92 encoding
a sponge system to miR19b or to the entire miR17-92 cluster
as has been described (38). To overexpress human PTEN we
used an inducible Tet-on expression system that has been
described (28). PTEN expression was induced upon induction
with 1µg/ml doxycycline. To knockdown PTEN expression
we used a viral vector encoding shPTEN [LENG.ShPten 1523,
(39)]. In some experiments, 38c13 cells were first infected with
FIGURE 1 | Ablation of miR17-92 in proB cells imposes a mild pro-to-pre B cell block and elevates expression of RAGs. (A) Representative flow cytometry analysis of
BM cells from mice with the indicated genotypes (3 mice from each genotype). Initial forward and side scatter gates were set to exclude dead cells and debris.
Numbers adjacent to outlined areas indicate % cells amongst total BM cells in each gate. The proB (B220 + IgM- AA4.1 + CD25- ckit+) and preB (B220 + IgM-
AA4.1 + CD25 + ckit-) populations are marked with arrows. Also shown are absolute cell counts. (B) The proB and preB cells were quantified for each individual
mouse and are expressed as proB/preB ratio. Plot depicts mean from 3 individual mice ± SE. (C) The proB, preB and mature B (B220 + IgM + AA4.1-) cells were
sorted from the gates shown in (A) and analyzed for relative expression of PTEN mRNA by qPCR and normalized to Hprt. Results are presented as mean from 3
individual mice ± SE. (D) Intracellular stain for PTEN and pAKT of BM cells gated on B220+/IgM- pro/pre B cells. Graph represents 2 mice in each group. (E) BM
culture wild-type pro/preB cells were treated with or without miR19b antagomirs for 48 h and analyzed for the indicated proteins by western blotting. (F) Sorted proB,
preB and mature B cells were analyzed for relative expression of RAG-1 (top) and RAG-2 (bottom) by qPCR normalized to Hprt. Graph depicts mean from 3 individual
mice ± SE.
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LENG.ShPten1523 vector and after selection the cells were
infected with pMSCV-PIG-sp19 to generate cells where PTEN is
knockdown and miR19b is suppressed.
Viral Packaging and Infection
Retroviral infections, virus production infection and selection of
cells were performed as we have described (28, 40).
Quantitative PCR
Quantitative PCR analysis for RAG-1 RAG-2, PTEN and Hprt
were performed as we have previously described (40). Briefly,
RNA was extracted by using Tri-Reagent (Sigma) and reverse
transcribed to cDNA (Promega). Real-time PCR was performed
using Syber green mix (Tiangen) using BioRad CFX connect
Real-Time PCR. Samples were normalized with Hprt gene
amplification. PCR product specificity was confirmed by melting
curve analysis where the crossover (Ct) values were used to
calculate gene specific input mRNA amount for each sample
according to the calibration curve method. DATA were analyzed
using the CFX Manager Software.
Luciferase Assay
To perform the luciferase reporter assay, 105 HEK cells per
well in 1ml of medium were seeded in 24-well plates for 24 h.
Cells were then transfected with the modified firefly luciferase
vector PmiRGLO- PTEN3’UTR or the PmirGLO-Foxo13′UTR
together with a vector encodingmiR17-92 or GFP using Calfectin
according to the manufacturer’s instruction. The 3’UTRs of
PTEN and Foxo1 were amplified from DNA isolated from
C57BL/6 mice by pcr and cloned into the pmirGLO vector. After
48 h the firefly and renilla luciferase activities were measured
with the dual-luciferase reporter assay system (Promega). To
control the transfection efficiency, firefly activity was normalized
to renilla activity.
Statistical Analysis
The statistical significance of the differences between
experimental groups was determined using unpaired two-
tailed Student’s t test with differences considered significant at p
< 0.05.
FIGURE 2 | PTEN overexpression partially blocks pro-to-pre B cell transition and elevates expression of RAGs. (A) Representative flow cytometry analysis of BM cells
from mice with the indicated genotypes (3–5 mice from each genotype). Initial forward and side scatter gates were set to exclude dead cells and debris. Numbers
adjacent to outlined areas indicate % cells amongst total splenocytes in each gate. Also shown are absolute cell counts. Total numbers of B cells in the BM were
calculated as total number of nucleated cells purified from one femur and one tibia multiplied by percentage of B220+ cells. (B) The proB and preB cells (gated as in
Figure 1 legend) were quantified for each individual mouse and are expressed as proB/preB ratio. Plot depicts mean from 3 to 5 individual mice ± SE. (C) The proB,
preB, and mature B cells were sorted using the indicated gates and analyzed for relative expression of RAG-1 (top) and RAG-2 (bottom) by qPCR normalized to Hprt.
Graph depicts mean from 3 to 5 individual mice ± SE.
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RESULTS
Ablation of miR17-92 in ProB Cells
Imposes a Mild Pro-to-Pre B Cell Block
With Elevated Expression of RAGs
We have shown that a c-Myc/miR17-92/PTEN axis regulates
PI3K activity for positive selection of immature B cells (28).
As PI3K signals are necessary to turn off RAG (17, 18, 20),
we tested whether the c-Myc/miR17-92/PTEN functions to
tune PI3K activity to control RAG expression during B cell
development. To do so in vivo, we used conditional mice enabling
altering the expression and/or activity of c-Myc/miR17-92/PTEN
axis in B lineage cells. We first generated mb1-Cre/miR17-
92f/f mice, where the entire miR17-92 cluster is conditionally
ablated in early proB cells (33). Analysis of BM cells in these
mice revealed a mild block at the proB stage as reflected by
a 2-fold increase in their frequency (Figure 1A) and by the
changed proB/preB cell ratio (Figure 1B). In agreement with
Lai et al (41), we found that ablation of miR17-92 resulted
in 15–20% increase in expression of PTEN mRNA in proB
and preB cells (Figure 1C) and PTEN protein (Figure 1D),
and reduced PI3K activity measured by Akt phosphorylation
(Figure 1D). These changes were also validated in pro/pre B
cells grown in BM cultures that were treated with miR19b
antagomirs (Figure 1E). To further validate these findings
in a reciprocal experiment we analyzed hCD2Cre/R26miR17-
92stopflox mice overexpressing miR17-92 in all lymphocytes
and found that PTEN expression is reduced in pro/pre B
cells whereas pAkt is increased (Supplementary Figure 1B).
Consistent with this and with our hypothesis, we found that
expression levels of both RAG-1 and RAG-2 were elevated
in preB cells from mb1-Cre/miR17-92f/f mice relative to the
FIGURE 3 | The c-Myc/miR17-92/PTEN axis regulates RAG expression in
38c13 cells through balancing PI3K activity. 38c13 cells were infected with
vector encoding miR19b sponge or shPTEN (to suppress miR19b or PTEN,
respectively) or with both, and stable transfectants were selected. (A)
Representative western blot for the indicated proteins (4 different
experiments). (B) The indicated stably transfected 38c13 cells were lyzed and
analyzed for relative RAG-1 and RAG-2 expression by qPCR normalized to
Hprt. Graph depicts mean of 4 experiments ± SE.
controls (Figure 1F). Despite of this mild pro-to-pre B cell block
we found no significant differences in splenic B cells (total
number and specific subsets, Supplementary Figure 1). These
findings suggest that intrinsic deletion of miR17-92 in proB cells
impairs the regulatory activity of the c-Myc/miR17-92/PTEN axis
to result in enhanced RAG expression and a partial pro-to-preB
block.
PTEN Overexpression Partially Blocks
Pro-to-Pre B Cell Transition and Elevates
Expression of RAGs
To confirm the function of the c-Myc/miR17-92/PTEN axis
in tuning RAG expression in early B cell development we
generated mb1-Cre/ROSA26STOPflox PTEN-2AYFP compound
mice (30), where selective over-expression of PTEN by about
15–20% is obtained in the B lineage starting from the proB
stage (Supplementary Figure 1C). Over-expression of PTEN in
these mice is encoded by PTEN cDNA and is therefore not
subjected to regulation by the miR17-92. Analysis of B cell
development and RAG expression in these compound mice
recapitulated our findings obtained in the miR17-92 ablated
mice (Figure 1). Thus, overexpression of PTEN imposed a
partial block at the proB stage as revealed by about 2-fold
increase in proB cell frequency (Figure 2A) and a changed
proB/preB cell ratio (Figure 2B). Similarly, overexpression
of PTEN, obtained by transduction of hematopoietic stem
cells (HSCs) with a lentivirus vector encoding human PTEN,
impaired B cell development as reflected by reduced frequencies
of total B cells in BM and spleen, and accumulation of
B220+/CD43 + cells (mostly proB cells). However, when the
transducing vector encoded a human PTEN construct ligated
FIGURE 4 | Over expression of PTEN suppresses PI3K and enhances RAG
expression in 38c13 cells. 38c13 cells were stably transfected with a Tet-on
inducible system to over-express human PTEN (PTEN-OE). Cells were treated
with doxycycline and analyzed after 24 h. (A) Representative western blot for
the indicated proteins (shown are three different clones for PTEN-OE). (B) The
stably PTEN-OE and control 38c13 cells were lyzed and analyzed for relative
RAG-1 and RAG-2 expression by qPCR normalized to Hprt. Graph depicts
mean of 3–6 experiments ± SE.
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FIGURE 5 | Regulation of RAG expression by the c-Myc/miR17-92/PTEN axis is mediated through Foxo1, but not through direct binding of miR17-92 to the Foxo1
3’UTR. (A) 38c13 cells were transfected with a sponge system to miR19b or to the entire miR17–92 cluster. Shown is a representative western blot for the indicated
proteins (from 3 experiments). (B) 38c13 cells were stably transfected with a Tet-on inducible system to over-express human PTEN (PTEN-OE). Cells were treated with
doxycycline and analyzed after 24 h lysed and analyzed by western blotting for the indicated proteins (shown are four different clones for PTEN-OE). (C) 38c13 cells
that are wild-type or transfected with the miR19b sponge system were cultured for 2 h in the presence of Foxo1 inhibitor. Cells were then lyzed and analyzed for
relative RAG-1 and RAG-2 expression by qPCR normalized to Hprt. Graph depicts mean of 3 experiments ± SE. (D) HEK cells were transfected with vector encoding
luciferase reporting system that is ligated to PTEN3′UTR or to Foxo1 3’UTR, together with a vector encoding miR17-92 or GFP. After 48 h luciferase activity was
determined. Graph depicts mean of 3 experiments ± SE. (E) 38-c13 cells that are wild-type control or transfected with the miR19b sponge system were lyzed and
relative Foxo1 mRNA was quantified by qPCR normalized to Hprt. Graph depicts mean of 3 experiments ± SE.
to a miR19b binding site [the major miRNA regulating PTEN
(32)] PTEN expression was suppressed and B cell development
was rescued (Supplementary Figure 2). Quantification of RAG
expression in sorted cells revealed that RAG-1 and RAG-
2 were significantly increased in proB and preB cells that
over-express PTEN (Figure 2C). These results suggest that
the autostimulatory c-Myc/miR17-92/PTEN axis tunes RAG
expression in B cell development through balancing PI3K
activity. Alteration of this axis, by either ablation of the miR17-
92 cluster or over-expression of PTEN, enhances expression
of RAG and partially blocks B cell development at the proB
stage.
The c-Myc/miR17-92/PTEN Axis Balances
PI3K Activity to Control RAG Expression in
38c13 Cells
To probe for the mechanism by which the c-Myc/miR17-
92/PTEN axis controls RAG expression we used the 38c13
immature B lymphoma cells which constitutively express RAG
(34). To alter c-Myc/miR17-92/PTEN axis in these cells we used
a sponge system specific to miR19b (38) to suppress expression
of this miRNA. We found that suppression of miR19b resulted
in a significant increase in expression of PTEN protein and a
consequential reduction in PI3K activity as revealed by Akt
phosphorylation (Figure 3A). Consistent with the reduced PI3K
activity, expression of RAG-1 and RAG-2 were significantly
enhanced by ∼2-fold relative to the control (Figure 3B).
Reciprocally, transfection with a vector encoding PTEN
specific shRNA [shPTEN (39)] enhanced Akt phosphorylation
significantly and suppressed expression of RAG-1 and RAG-2 by
∼2-fold relative to the control (Figures 3A,B). Furthermore, in
cells co-transfected with miR19b-sponge and shPTEN, activity
of PI3K was enhanced to effectively suppress RAG expression
(Figures 3A,B), suggesting that the increased expression of
RAG induced by the miR19b-sponge system is mediated via
alteration of PTEN expression. Consistent with the regulatory
feedback of the c-Myc/miR17-92/PTEN axis we show that
reduced PI3K activity obtained by suppression of miR19b
reduced expression of MYC whereas enhanced PI3K activity
obtained by suppression of PTEN enhanced MYC expression
(Figure 3A).
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To further validate this, we infected 38c13 cells with a vector
encoding an inducible system for human PTEN expression
[PTEN-OE (42)]. Over expression of PTEN in these cells
was evident by PTEN protein level and a suppressed PI3K
activity (revealed by Akt phosphorylation) in the selected
subclones (Figure 4A). In agreement with the results obtained
upon introducing the miR19b-sponge system (Figure 3), we
found that RAG-1 and RAG-2 were significantly elevated in
38c13 cells over-expressing PTEN (Figure 4B). Collectively,
these results confirmed that in 38c13 cells the regulation of
RAG expression is mediated by the c-Myc/miR17-92/PTEN
axis.
Regulation of RAG Expression by the
C-Myc/miR17-92/PTEN Axis Is Mediated
Post-translationally Through Foxo1, but
Not Post-transcriptionally Through Direct
Binding of miR17-92 to the Foxo1 3′UTR
Previous studies have shown that regulation of RAG by PI3K
is mediated post-translationally through phosphorylation and
inactivation of Foxo1 (17, 18). In agreement with this we
find elevated expression of Foxo1 in 38c13 cells transfected
with miR17-92 or the miR19b sponge (Figure 5A), or over-
expressing PTEN (Figure 5). Moreover, we show that the
induction of RAG expression obtained upon transfection with
the miR19b sponge system is blocked by a Foxo inhibitor
(Figure 5C), suggesting that the regulatory effects of the c-
Myc/miR17-92/PTEN axis on RAG expression are mediated
by Foxo1. Yet, bioinformatic analysis of the Foxo1 3′UTR
(using the TargetScanHuman program; http://www.targetscan.
org) revealed a potential binding site for miR19b, proposing
a direct post-transcriptional regulatory effect of miR19b on
expression of Foxo1. To test this we transfected human
embryonic kidney (HEK) cells with a vector encoding luciferase
reporter ligated to Foxo1 3′UTR or PTEN 3’UTR, together with
a vector encoding miR17-92 or GFP control. The results in
Figure 5D show that miR17-92 significantly reduced luciferase
activity in HEK cells transfected with a luciferase reporter
ligated to PTEN 3’UTR, whereas no change was recorded in
HEK cells transfected with luciferase reporter ligated to Foxo1
3′UTR. Moreover, quantification of Foxo1 mRNA in 38c13 cells
transfected with miR19b sponge revealed no significant change
relative to control cells (Figure 5E). These results suggest that
regulation of Foxo1 expression by the c-Myc/miR17-92/PTEN
axis is mediated post-translationally through balancing PI3K
activity.
Overexpression of miR17-92 Suppressed
RAG Expression in Developing CD19KO B
Cells
To address physiological roles of the c-Myc/miR17-92/PTEN
axis in controlling RAG expression during B cell development
we used CD19KO mice, where RAG expression in developing
B cells does not turn off (9) owing to impaired PI3K signaling
(20, 43). Consequentially, B cell maturation in CD19KO mice
is impaired with evidence for ongoing Ig gene rearrangements
(9, 19, 44). Overexpression of miR17-92 (28) or loss of PTEN
(45) in developing CD19KO B cells enhanced PI3K activity,
to effectively reconstitute maturation and differentiation of
CD19KO B cell (28). The results in Figure 6 show that enhancing
PI3K activity through overexpression of miR17-92 effectively
suppressed RAG expression in developing CD19KO miR17-
92Tg B cells to promote their differentiation in BM cultures.
Thus, while RAG-1 and RAG-2 expression were significantly
elevated in developing CD19KO B cells (∼18 and ∼5-fold,
respectively), expression of both RAGs in developing CD19KO
miR17-92Tg B cells was suppressed to a level that is not
different from that found in developing control B cells. These
results suggest that reconstitution of B cell development and
maturation in CD19KO miR17-92Tg mice is mediated by the
suppression of RAG expression, which is in turn mediated
through tuning PI3K activity by the c-Myc/miR17-92/PTEN
axis.
Enhanced PI3K Activity Abolishes RAG
Expression and Blocks B Cell Development
at the Early proB Stage
In all mouse models detailed here earlier (miR17-92 ablated,
PTEN-over expression and CD19KO) B cell development
is perturbed due to a low PI3K activity and enhanced
RAG expression, resulting from reduced activity of the c-
Myc/miR17-92/PTEN axis. To further confirm the importance
of this axis we performed a reciprocal experiment and tested
whether constitutively active PI3K would suppress RAG gene
expression in developing B cells to impair their development.
To do so, we generated mice carrying a conditional allele
encoding constitutively active PI3K subunit P110α [P110∗ (16)]
specifically expressed in the B lineage starting at the early proB
stage (mb1-Cre/ROSA26STOPflox-P110∗ compound mice). As
shown in Figure 7, the enhanced PI3K activity blocked B
cell development at the early proB stage (ckit-/CD25-) with
only few proB (cKit+/CD25-) and preB cells (cKit-/CD25+)
detected (Figure 7A), explaining the nearly complete absence of
B220+/IgM+ cells in the BM (Figure 7A). Analysis of RAG in
sorted proB and preB cells from mb1-Cre/ROSA26STOPflox-
P110∗ mice revealed a significantly suppressed expression in
both B cell subsets relative to control (Figure 7B). These results
suggest that enhanced PI3K activity suppresses RAG expression
to block B lymphopoiesis.
DISCUSSION
This study suggests that the autostimulatory c-Myc/miR17-
92/PTEN axis functions as a post-translational mechanism
balancing the PI3K/Foxo1/RAG pathway during early stages of B
cell development. We show that modification of this axis altered
expression of RAGs and impacted B cell development. Hence,
while BCR-mediated PI3K signaling is most important for B
cell development and survival, the c-Myc/miR17-92/PTEN axis
functions to properly tune it for regulation of RAGs and to
promote developmental progression.
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FIGURE 6 | Overexpression of miR17-92 suppresses RAG in developing CD19KO B cells. IL-7-driven BM cultures from mice of the indicated genotypes were
prepared. (A) Cells grown were harvested on day 5, stained for the indicated surface markers and analyzed by FACS. Initial forward and side scatter gates were set to
exclude dead cells and debris. Shown are representative plots from 3 to 4 mice from each group. (B) Cells were lyzed and relative RAG-1 and RAG-2 mRNA was
quantified by qPCR normalized to Hprt. Graph depicts mean of 3–4 mice from each group ± SE.
The mechanism by which the c-Myc/miR17-92/PTEN axis
balances the PI3K/Foxo1/RAG pathway in B cell development is
illustrated in Figure 8. In developing B cells the PI3K/Akt/Foxo1
is most important to control RAG expression. Both, enhanced
or suppressed PI3K significantly impact RAG expression and
consequentially alter B cell development. Thus, enhanced PI3K
activity obtained upon ablation of PTEN suppresses RAG
expression and blocks B cell development at the proB stage
(22), whereas deficiency of CD19 (9), or lack of the p85(alpha)
regulatory subunit of PI3K (20) suppresses PI3K activity to result
in ongoing RAG expression and Ig gene rearrangements (9, 19,
44). This study shows that the PI3K activity in developing B cells
is balanced by the c-Myc/miR17-92/PTEN axis for appropriately
controlled RAG expression (Figure 8). Accordingly, we show
that altering the c-Myc/miR17-92/PTEN axis, by deletion of
miR17-92 or by overexpressing PTEN, suppressed PI3K activity,
led to enhanced RAG expression in early developing B cells,
and imposed a mild pre-to-pro B cell block (Figures 1, 2). A
similar mild pro-to-pre B cell block is also evident in CD19-/-
mice, although RAG expression levels in pro and pre B cells
were not measured in this study (46). Yet, in all these mutated
mouse models significant B cell development is still observed,
as revealed by the number of mature B cells in BM and spleen,
probably suggesting the existence of compensatory mechanisms
to enhance PI3K activity (9, 44). In agreement with this,
Sandoval et al reported that cycling large preB cells express
MYC and high level of inactivated (phosphorylated) Foxo1,
whereas non-cycling preB cells do not have MYC protein but
have abundant expression of RAG and DNA rearrangements
(47).
On the other hand, it is more difficult to compensate for
enhanced PI3K activity as B cell development in PTEN-ablated
mice or transgenic for P110∗ is blocked at the proB or early proB
stage [respectively, (22) and Figure 7]. Owing to the increased
PI3K activity and the resulting enhanced phosphorylation and
degradation of Foxo1, RAG expression in pro and pre B cells
from these mice was too low and probably insufficient to
promote Ig gene rearrangements. This loss of Foxo1 also impairs
expression of the transcription factor Ikaros that is necessary for
Ig gene rearrangements (22). Remarkably, in the P110∗ mice B
cell development is blocked at an earlier stage relative to that
observed in RAG-deficient mice (pre-proB in P110 relative to
proB in RAG-/-), suggesting that in addition to the suppression
of RAG other mechanisms may be involved. Studies have shown
that developmental progression from pre-proB to the preB stage
is mediated through transcriptional regulation by EBF or E2A
(48), as well as by expression and signaling of the proBCR
(8, 49). Hence, it is possible that the overly activated PI3K
in the P110∗ mice impairs expression and/or function of EBF
and E2A, or alters expression and signaling of the proBCR to
abort B cell development at the pre-proB stage. In addition,
transcription from the RAG locus is required for transition into
the earliest lymphoid progenitor stage (50). In RAG–/– mice this
transcription allows differentiation to proB cells but not beyond
Frontiers in Immunology | www.frontiersin.org 8 November 2018 | Volume 9 | Article 2715
Benhamou et al. MYC/miR17-92/PTEN Tunes RAG in B Lymphopoiesis
FIGURE 7 | Enhanced PI3K activity abolishes RAG expression and blocks B cell development at the early proB stage. (A) Representative flow cytometry analysis of
BM cells from mice with the indicated genotypes (3 mice from each genotype). Initial forward and side scatter gates were set to exclude dead cells and debris. Also
shown are absolute cell counts. (B) The proB and preB cells were sorted using the indicated gates and analyzed for relative expression of RAG-1 (top) and RAG-2
(bottom) by qPCR normalized to Hprt. Graph depicts mean from 3 individual mice ± SE.
due to the non-functional RAG mutation. It is possible that
the overly activated PI3K blocks this transcription and prevents
development of pre-proB to a proB stage in the P110∗ mice.
In mature B cells a PI3K/Akt/Foxo1 pathway has been
shown to control survival (16). Interestingly, suppressing PI3K
by chemical inhibitors or by ablating biogenesis of miRNAs
stimulates expression of RAG in mature splenic B cells (27). As
tonic PI3K activity increases with B cell maturation to promote
survival (3), it is possible that the increased PI3K activity is also
important to prevent re-expression of RAGs in peripheral B cells.
Thus, during B cell development in the BM the c-Myc/miR17-
92/PTEN axis regulates PI3K for RAG expression (this study) and
for positive and negative selection of immature B cells (28), but
the regulatory circuits balancing tonic PI3K activity for survival
and to seal-off RAG expression are less known.
The enhanced expression of RAG in developing B cells was
delayed to some extent in miR17-92-ablated mice relative to
PTEN over expressing mice. Thus, while differences in RAGs
were detected only in preB cells in miR17-92-ablated mice,
significant elevation in RAGs was readily seen already in proB
cells in PTEN over expressing mice. We attribute this to the
elapsing time from genomic deletion until actual affecting PI3K
activity. Thus, in PTEN over expressing mice PI3K activity was
immediately suppressed due to the enhanced PTEN activity,
whereas genomic ablation of the miR17-92 cluster did not
immediately abolish all mature miRNAs of this cluster, which
continue to function until degradation based on their turnover
rate (51). A similar delayed effect was evident when PI3K
activity was enhanced in PTEN-ablated mice (22) relative to
P110∗ Tg mice (Figure 7). Thus, genomic ablation of PTEN does
not abolish the function of residual PTEN mRNA and protein
in balancing PI3K for development until they are degraded,
allowing development up to proB stage. In the P110∗Tg mice
though, we observed a block earlier at the early pro B stage which
is driven by the enhanced PI3K activity in these cells.
Interestingly, in mb1-Cre miR17-92fl/fl mice we observed a
mild block in B cell development compared to that obtained
when miR17-92 is ablated early in hematopoietic progenitors
(29), or when the miR17-92 is deleted together with its paralog
clusters miR106a-363 and miR106b-25 (41). It is possible that
an early deletion of the miR17-92 cluster in the hematopoietic
lineage may affect commitment and differentiation into the B
lineage, and loss of all paralog clusters aborts all regulatory and
compensatory functions by this group of miRNAs. Nevertheless,
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FIGURE 8 | An illustration proposing a mechanism by which the
MYC/miR17-92/PTEN axis balances the PI3K/Foxo1/RAG pathway in
developing B cells. Signals generated by the antigen receptor activate
PI3K/Akt to phosphorylate and inactivate Foxo1, leading to suppression of
RAG. We propose that in developing B cells PI3K activation is balanced by the
autostimulatory MYC/miR17-92/PTEN axis (shown in red). Accordingly, c-Myc
regulates expression of miR-17-92 which reduces expression of PTEN to
enhance PI3K activity and promote suppression of RAG.
the block at the proB cell stage that is readily observed in
Ventura et al (29), in Nojima et al (52) and here indicates the
cell-autonomous important function of the miR17-92 cluster in
promoting B cell development at this developmental check-point.
In addition to PTEN, several studies have shown that the
miR17-92 controls other important genes regulating the pro-to-
preB cell transition such as E2F family of transcription factors
(53), as well as the pro-apoptotic Bim (29). Moreover, Lai et al
have shown that loss of one PTEN allele fails to rescue B cell
development in mice where the miR17-92 is deleted together
with its paralog clusters miR106a-363 and miR106b-25 (41).
Thus, the miR17-92 cluster and its paralogs are critical for B
cell development by regulating multiple target genes controlling
developmental transition. The mild pro-to-pre B cell block we
show here in miR17-92-deleted or PTENover mice supports this.
Finally, PI3K is most critical for HSCs maintenance and
lineage differentiation (54, 55). High level of PI3K (obtained by
constitutive active Akt or by PTEN heterozygosity) promotes
leukemia and aplastic BM, whereas low level of PI3K prevents
self-renewal and differentiation (56, 57). The regulation of PI3K
activity in HSCs is unknown. Studies indicate that multipotent
HSCs depend on Dicer and miRNA biogenesis for persistence
(58), and that PTEN expression regulates HSCs activity by
repressing the PI3K/Akt/mTor signaling (59). It is possible that
the c-Myc/miR17-92/PTEN axis may also function to regulate
PI3K in HSCs. Alternatively, the PTEN-PI3K relationship in
balancing PI3K activity may be regulated in the hematopoietic
compartment by a different miRNA. Thus, while balancing
PI3K is most critical for hematopoiesis in general, the present
work proposes that in the B lineage lymphopoiesis PI3K
activity is strictly balanced by the c-Myc/miR17-92/PTEN axis
to regulate RAG expression and to promote developmental
progression.
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